http://www.reuters.com/article/pressRelease/idUS154656+08-Sep-2009+BW20090908
Teva will present data on the effect of COPAXONE® on the Multiple Sclerosis
Severity Score (MSSS) from the longest ongoing prospective study of an
immunomodulatory therapy in RRMS. In addition, Teva and Active Biotech (NASDAQ
OMX NORDIC: ACTI) will present data on laquinimod, its investigational oral,
once-daily, immunomodulating compound being developed for the treatment of RRMS.
New data on ATL/TV1102, a second generation antisense inhibitor of CD49d, a
subunit of VLA-4, for the treatment of RRMS patients, will be presented as well.
- Forums
- ASX - By Stock
- teva conference presentation
http://www.reuters.com/article/pressRelease/idUS154656+08-Sep-200...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.61M |
Open | High | Low | Value | Volume |
7.3¢ | 7.5¢ | 7.1¢ | $52.15K | 724.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8095 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
3 | 33055 | 0.068 |
1 | 9310 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8095 | 1 |
0.077 | 50000 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |